Amerisource Inks $625M FCA Deal In 'Sham Pharmacy' Row
AmerisourceBergen Corp. will pay $625 million to end False Claims Act suits accusing it of flouting federal oversight in a massive "sham pharmacy" scheme to repackage and resell drugs used by...To view the full article, register now.
Already a subscriber? Click here to view full article